LEUPROGEL

Details for Australian Trade Mark No. 862833 (hide)

Owner Atrix Laboratories, Inc. a Delaware corporation

Service FB Rice

Various Convention priority claimed: 14 July 2000, United States of America, No. 76/089157 in respect of PHARMACEUTICAL PREPARATIONS AND DRUG DELIVERY SYSTEM FOR THE TREATMENT OF PROSTATE CANCER.*

Classes

Class 5 Pharmaceutical preparations; pharmaceutical preparations being therapeutic products combining an active therapeutic ingredient or ingredients with a drug delivery system in the form of a substance providing either a timed or staged release of active ingredients or a vector delivery of active therapeutic ingredients to either specific sites or across barriers ordinarily impervious to said therapeutic ingredients; pharmaceutical preparations being drug systems in this class as aforesaid

Event Publications

4 August 2011 Trade Mark Removed from the Register / IR Expired

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

862834-ATRISONE

862832-HOLCIM